Nixon Gwilt Law

NOVEMBER 8, 2024

CMS issued its 2025 Medicare Physician Fee Schedule (the “2025 MPFS” or “Final Rule”) on November 1, 2024. The Final 2025 MPFS contains some modifications and clarifications to several elements of the original proposal released in July 2024 (the “Proposed Rule”), which we discussed in this earlier post.

FDA 52

FDA Physicians Management Patients 52

European Pharmaceutical Review

OCTOBER 17, 2024

However, reports and surveys say that only half of people with an epinephrine needle-injector prescription consistently carry their device, 4 and for patients and caregivers who do carry a needle-injector, more than half either delay or do not administer it in an emergency. Motohiro E, Kento T, Kyohei T , et al.

Food and Drug Administration 121

Food and Drug Administration Medicine Consulting Food 121

PM360

AUGUST 9, 2022

billion in 2025. The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. from 2021 and reach $4.2

Prescription 105

Prescription Medical Patients Side effects 105

Copyright Clearance Center

DECEMBER 10, 2024

By standardizing the terminology used to describe substances, the Alliances IDMP Ontology will aid compliance, and enable safer cross-border prescriptions. He highlighted how collaborations on harmonizing data standards have improved regulatory review practices and enabled predictive models to enhance drug safety.

Prescription 52

Prescription Patients FDA Safety 52

Clarivate

MAY 13, 2024

After staying relatively flat for several years, enrollment growth took off in 2021 after an expansion in federal subsidies for silver-level plans passed in the American Rescue Plan and was then renewed through 2025 in the Inflation Reduction Act.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

Pharmaceutical Technology

JUNE 1, 2023

For context, in January 2023, the FDA accepted Intercept’s resubmission of its NDA for OCA as a Class 2 resubmission (which has a six-month review period in NASH) and set a Prescription Drug User Fee Act (PDUFA) date of 22 June 2023.

FDA 52

FDA Side effects Prescription Patients 52

Nixon Gwilt Law

NOVEMBER 8, 2024

CMS issued its 2025 Medicare Physician Fee Schedule (the “2025 MPFS” or “Final Rule”) on November 1, 2024. The Final 2025 MPFS contains some modifications and clarifications to several elements of the original proposal released in July 2024 (the “Proposed Rule”), which we discussed in this earlier post.

FDA 52

FDA Physicians Management Patients 52